tradingkey.logo

Nomura initiates coverage on India's Anthem Biosciences with 'buy'; shares rise

ReutersNov 28, 2025 7:30 AM

Nomura initiates coverage on Anthem Biosciences ANTH.NS with "buy," target price of 740 rupees - representing an 18% premium on last close

Shares of ANTH rise as much as 3.6% to 651 rupees, last up ~1%

Nomura says ANTH can sustain 17% growth in CY24–29, outpacing industry’s 13% growth in the contract research, development and manufacturing organisation segment

Adds, co has a wider customer base and a strong "fee for service" strategy vs peers

Anthem's stable leadership with employee attrition below peers has led strong operating performance with industry-leading profit margins and return ratios - Nomura

Believes ANTH's key molecules' growth, new launches and capacity expansion are key positives for medium-term growth

ANTH down 13% since listing on July 21

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI